OBLIQUE THERAPEUTICS Trademark

Trademark Overview


On Thursday, November 1, 2018, a trademark application was filed for OBLIQUE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OBLIQUE THERAPEUTICS trademark a serial number of 88178276. The federal status of this trademark filing is REGISTERED as of Tuesday, April 27, 2021. This trademark is owned by Oblique Therapeutics AB. The OBLIQUE THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development regarding pharmaceuticals and pharmaceutical preparations; Research and development for the pharmaceutical industry; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting early evaluations in the field of new pharmaceuticals; Medical research in the field of cancer; Pharmaceutical research; Biological research; Bacteriological research; Scientific research for medical purposes in the area of cancerous diseases; Cell separation technology research services; Medical research laboratory services; Laboratory research services relating to the production of monoclonal antibodies; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Scientific research and development; Science and technology research services in the field of medicine; Technological analysis services in the field of medical research
oblique therapeutics

General Information


Serial Number88178276
Word MarkOBLIQUE THERAPEUTICS
Filing DateThursday, November 1, 2018
Status700 - REGISTERED
Status DateTuesday, April 27, 2021
Registration Number6335551
Registration DateTuesday, April 27, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements


Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesResearch and development regarding pharmaceuticals and pharmaceutical preparations; Research and development for the pharmaceutical industry; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Conducting early evaluations in the field of new pharmaceuticals; Medical research in the field of cancer; Pharmaceutical research; Biological research; Bacteriological research; Scientific research for medical purposes in the area of cancerous diseases; Cell separation technology research services; Medical research laboratory services; Laboratory research services relating to the production of monoclonal antibodies; Laboratory research services relating to pharmaceuticals; Pharmaceutical products development; Scientific research and development; Science and technology research services in the field of medicine; Technological analysis services in the field of medical research

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 16, 2018
Primary Code042
First Use Anywhere DateThursday, December 31, 2015
First Use In Commerce DateThursday, December 31, 2015

Trademark Owner History


Party NameOblique Therapeutics AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressGöteborg 41346
SE

Party NameOblique Therapeutics AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGöteborg 41346
SE

Party NameOblique Therapeutics AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
Address413 46 Göteborg
SE

Trademark Events


Event DateEvent Description
Tuesday, April 27, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 23, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Saturday, March 20, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, March 17, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 16, 2021STATEMENT OF USE PROCESSING COMPLETE
Tuesday, March 2, 2021USE AMENDMENT FILED
Tuesday, March 16, 2021EXTENSION 3 GRANTED
Tuesday, March 2, 2021EXTENSION 3 FILED
Tuesday, March 16, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, March 2, 2021TEAS EXTENSION RECEIVED
Tuesday, March 2, 2021TEAS STATEMENT OF USE RECEIVED
Friday, August 14, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 12, 2020EXTENSION 2 GRANTED
Wednesday, August 12, 2020EXTENSION 2 FILED
Wednesday, August 12, 2020TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 20, 2020EXTENSION 1 GRANTED
Thursday, February 20, 2020EXTENSION 1 FILED
Thursday, February 20, 2020TEAS EXTENSION RECEIVED
Thursday, February 20, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 20, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 3, 2019ASSIGNED TO LIE
Tuesday, May 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 20, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 20, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, May 20, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019NON-FINAL ACTION E-MAILED
Thursday, February 7, 2019NON-FINAL ACTION WRITTEN
Thursday, February 7, 2019ASSIGNED TO EXAMINER
Friday, November 16, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 5, 2018NEW APPLICATION ENTERED IN TRAM